Advancements in Cancer Treatments

Dr. Daniel Harki is the Northrop Professor at the University of Minnesota and principal investigator (PI) of the Harki laboratory, which focuses on the design, synthesis, and characterization of small molecules for applications in anticancer and antiviral drug discovery.

Dr. Harki is the Associate Department Head for Research and the Director of Graduate Studies for the Department of Medicinal Chemistry at the University of Minnesota. Additionally, Dr. Harki is co-Leader of the Cellular Mechanisms Program at the University of Minnesota Masonic Cancer Center.

Dr. Harki is an Associate Editor for Medicinal Research Reviews (Wiley).

Dr. Harki is the Chair of Membership and International Relationships for the American Chemical Society (ACS) Division of Medicinal Chemistry (MEDI).